Differences in the effects of acute and chronic administration of dexfenfluramine on cortisol and prolactin secretion.
Oliver
C
C
Laboratoire de Neuroendocrinologie Expérimentale, INSERM U 297, Faculté de Médecine Nord, Marseille, France.
Jezová
D
D
Grino
M
M
Guillaume
V
V
Boudouresque
F
F
Conte-Devolx
B
B
Pesce
G
G
Dutour
A
A
Becquet
D
D
D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000328:Adult; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D003345:Corticosterone / Q000494:pharmacology; D003346:Corticotropin-Releasing Hormone / Q000494:pharmacology; D005260:Female; D005277:Fenfluramine / Q000494:pharmacology*; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism*; D008297:Male; D010904:Pituitary Gland, Posterior / Q000378:metabolism; D011169:Portal Vein; D011388:Prolactin / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors
D005277:Fenfluramine; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D003346:Corticotropin-Releasing Hormone; D003345:Corticosterone; D006854:Hydrocortisone